SOLID RENAL MASS
Hisham AlKhatib, M.D.
Consultant Radiologist
•‫اله‬ ‫وعلى‬ ‫هللا‬ ‫رسول‬ ‫على‬ ‫والسالم‬ ‫والصالة‬ ‫هلل‬ ‫الحمد‬
‫اجمعين‬ ‫م‬ّ‫ل‬‫وس‬ ‫وصحبه‬
•، ‫علما‬ ‫وزدني‬ ‫ينفعني‬ ‫بما‬ ‫وعلمني‬ ‫علمتني‬ ‫بما‬ ‫انفعني‬ ‫اللهم‬
‫الحكيم‬ ‫العليم‬ ‫انك‬
• Praise be to Allah and prayers be upon the
Messenger of Allah and his family and
companions.
• Oh God, give me the benefit of what you
have taught me and teach me what benefits
me.
ESSENTIAL INFORMATION
Key Differential Diagnosis Issues
• Solid, expansile mass in adult is usually renal cell
carcinoma, unless
– Mass contains fat (probably angiomyolipoma)
– Patient has fever, urosepsis (consider pyelonephritis
and renal abscess)
– Patient is immunocompromised (consider lymphoma,
posttransplant lymphoproliferative disorder)
– Patient has known other primary cancer (consider
metastases)
Key Differential Diagnosis Issues
• Role of biopsy is evolving but definitely has role in
diagnosing renal lymphoma and metastases
– Useful in diagnosing oncocytoma, angiomyolipoma
(AML)
– Morphology and immunohistochemical features are
key pathologic findings
– Routinely performed prior to percutaneous ablation: ~
20% of small (< 4 cm) enhancing renal masses are
benign (i.e., non-fat-containing AML, oncocytoma)
Key Differential Diagnosis Issues
• Morphology of lesion also aids diagnosis:
“beans” vs. “balls”
– Infiltrating tumor maintains reniform (“bean”)
shape: Consider urothelial carcinoma, collecting
duct carcinoma, medullary carcinoma
– Well-circumscribed (“ball”) tumor: Consider renal
cell carcinoma (RCC) (clear cell, papillary,
chromophobe)
Key Differential Diagnosis Issues
• Clinical history is key in diagnosing renal
trauma, infection, metastases, lymphoma
– Not usually helpful in diagnosing primary renal
tumors
• CT or MR evaluation of renal mass must
include nonenhanced and parenchymal phase
images
– Arterial phase good for diagnosing column of
Bertin; pyelographic phase essential for
diagnosing transitional cell cancer
DIFFERENTIAL DIAGNOSIS
Common Diagnosis
• Renal Cell Carcinoma
• Wilms Tumor (Nephroblastoma)
• Column of Bertin (Mimic)
• Fetal Lobulation
• Pyelonephritis
Helpful Clues for Common
Diagnoses
Renal Cell Carcinoma
• Usually discovered as incidental finding
– May have hematuria or flank pain
Renal Cell Carcinoma
• Variable appearance and histology
– From mostly cystic, to hypovascular (papillary), to
hypervascular (most RCCs)
– Large tumors may have lipoid degeneration,
invade renal sinus perirenal fat, simulate
angiomyolipoma
– Large tumors may also have osseous metaplasia
Renal Cell Carcinoma
• Variable appearance and histology (continued)
– Common RCC subtypes (WHO classification): Clear
cell, papillary, chromophobe
– Additional rare, aggressive renal epithelial tumors
may be suggested by central infiltrative growth
pattern (collecting duct, medullary carcinoma)
Renal Cell Carcinoma
• Large RCC with predilection for renal vein,
inferior vena cava invasion
Wilms Tumor (Nephroblastoma)
• Most common solid renal mass in children
• Highly variable appearance
Column of Bertin (Mimic)
• Hypertrophied column of septal cortex that
protrudes into renal sinus
– Usually between upper and middle calyces
• Same enhancement characteristics (and
echogenicity) as renal cortex
• Utilize power (color) Doppler to confirm
similar vascularity of adjacent cortex if
identified at screening ultrasound
Fetal Lobulation
• Persistent cortical lobulation, reflecting fetal
renal development as multiple separate lobes
• Enhances like normal cortex and medulla
Pyelonephritis
• Severe focal pyelonephritis, renal abscess, or
xanthogranulomatous pyelonephritis may be
indistinguishable from tumor by imaging
alone
• Consider clinical presentation; needle
aspiration and drainage of abscess
Less Common Diagnosis
• Hyperdense Renal Cyst (Mimic)
• Angiomyolipoma, Renal
• Renal Oncocytoma
• Metastases and Lymphoma, Renal
• Urothelial Cell Carcinoma
• Pyelonephritis, Xanthogranulomatous
• Renal Trauma
• Aneurysm, Renal Artery (Mimic)
• Arteriovenous Malformation, Renal (Mimic)
Helpful Clues for Less Common
Diagnoses
Hyperdense Renal Cyst (Mimic)
• High-density (“hyperdense” or “hemorrhagic”) renal
cyst is indistinguishable from tumor on either NECT
or CECT alone
– Cyst will not enhance, while viable tumor almost always
enhances ≥ 20 HU (beware papillary RCC)
– Sonography useful to show sonolucent contents and
acoustic enhancement of hyperdense cyst
– Large cyst with extensive hemorrhage may be impossible
to distinguish from necrotic tumor
– Attenuation > 70 HU at NECT strongly suggests high-
attenuation (“hyperdense”) CT rather than RCC
Angiomyolipoma, Renal
• Most common benign renal solid mass
• 95% have identifiable fat on CT or MR
– Use NECT or MR to identify small foci of fat
– AML without fat is difficult or impossible to distinguish
from RCC by imaging (often hyperdense to kidney on
NECT)
– Highly echogenic at ultrasound, though imaging overlap
with small echogenic RCC
• Features favoring RCC: Halo, cystic components
• Multiple and bilateral in tuberous sclerosis
• May result in spontaneous bleeding
Renal Oncocytoma
• Benign epithelial tumor
• Often has central stellate scar (30-50%), though not
specific finding
• Segmental inversion pattern suggested, though
specificity also disputed
– Hypervascular component on corticomedullary phase
deenhances on nephrographic phase
– Hypovascular component on corticomedullary phase
retains contrast on nephrographic phase
Metastases and Lymphoma, Renal
• Often multiple, in patient with known primary
tumor
• Usually less vascular and less exophytic than RCC
• Multiple renal lymphoma patterns: Multifocal or
infiltrating tumor, diffuse bilateral enlargement
• Consider lymphoma if large tumor and
retroperitoneal adenopathy without renal vein
invasion
Urothelial Cell Carcinoma
• More infiltrative, less expansile than RCC
• May be part of multifocal tumor
– Bladder > kidney > ureter
• Most low-grade, superficial papillary masses
• 15% aggressive: Invade renal sinus and
parenchyma
Renal Trauma
• Renal hematoma may be indistinguishable
from tumor
– History (including possible invasive procedure like
biopsy) is key
• Traumatic injury will evolve quickly
Aneurysms and Arteriovenous
Malformations (Mimic)
• Vascular lesions can mimic tumor
• Key is multiphasic CT or MR during rapid bolus
of contrast medium or color Doppler
Rare but Important
• Renal Medullary Carcinoma
• Renal Tumors, Atypical and Rare
– Mesenchymal Tumor, Renal
– Juxtaglomerular Tumor
– Plasmocytoma, Renal
– Small Cell Carcinoma, Renal
Helpful Clues for Rare Diagnoses
Renal Medullary Carcinoma
• Rare, highly aggressive tumor
• Usually affects men with sickle cell trait
Renal Tumors, Atypical and Rare
• May arise from any mesenchymal component
of renal capsule, cortex, or medulla
• Generally cannot be diagnosed by imaging
Alternative Differential
Approaches
• Lesions that may be hyperdense on NECT:
Hyperdense cyst, RCC, oncocytoma, nonfat-
containing AML, transitional cell carcinoma
THANK YOU

Solid renal mass

  • 1.
    SOLID RENAL MASS HishamAlKhatib, M.D. Consultant Radiologist
  • 2.
    •‫اله‬ ‫وعلى‬ ‫هللا‬‫رسول‬ ‫على‬ ‫والسالم‬ ‫والصالة‬ ‫هلل‬ ‫الحمد‬ ‫اجمعين‬ ‫م‬ّ‫ل‬‫وس‬ ‫وصحبه‬ •، ‫علما‬ ‫وزدني‬ ‫ينفعني‬ ‫بما‬ ‫وعلمني‬ ‫علمتني‬ ‫بما‬ ‫انفعني‬ ‫اللهم‬ ‫الحكيم‬ ‫العليم‬ ‫انك‬ • Praise be to Allah and prayers be upon the Messenger of Allah and his family and companions. • Oh God, give me the benefit of what you have taught me and teach me what benefits me.
  • 3.
  • 4.
    Key Differential DiagnosisIssues • Solid, expansile mass in adult is usually renal cell carcinoma, unless – Mass contains fat (probably angiomyolipoma) – Patient has fever, urosepsis (consider pyelonephritis and renal abscess) – Patient is immunocompromised (consider lymphoma, posttransplant lymphoproliferative disorder) – Patient has known other primary cancer (consider metastases)
  • 5.
    Key Differential DiagnosisIssues • Role of biopsy is evolving but definitely has role in diagnosing renal lymphoma and metastases – Useful in diagnosing oncocytoma, angiomyolipoma (AML) – Morphology and immunohistochemical features are key pathologic findings – Routinely performed prior to percutaneous ablation: ~ 20% of small (< 4 cm) enhancing renal masses are benign (i.e., non-fat-containing AML, oncocytoma)
  • 6.
    Key Differential DiagnosisIssues • Morphology of lesion also aids diagnosis: “beans” vs. “balls” – Infiltrating tumor maintains reniform (“bean”) shape: Consider urothelial carcinoma, collecting duct carcinoma, medullary carcinoma – Well-circumscribed (“ball”) tumor: Consider renal cell carcinoma (RCC) (clear cell, papillary, chromophobe)
  • 7.
    Key Differential DiagnosisIssues • Clinical history is key in diagnosing renal trauma, infection, metastases, lymphoma – Not usually helpful in diagnosing primary renal tumors • CT or MR evaluation of renal mass must include nonenhanced and parenchymal phase images – Arterial phase good for diagnosing column of Bertin; pyelographic phase essential for diagnosing transitional cell cancer
  • 8.
  • 9.
    Common Diagnosis • RenalCell Carcinoma • Wilms Tumor (Nephroblastoma) • Column of Bertin (Mimic) • Fetal Lobulation • Pyelonephritis
  • 10.
    Helpful Clues forCommon Diagnoses
  • 11.
    Renal Cell Carcinoma •Usually discovered as incidental finding – May have hematuria or flank pain
  • 12.
    Renal Cell Carcinoma •Variable appearance and histology – From mostly cystic, to hypovascular (papillary), to hypervascular (most RCCs) – Large tumors may have lipoid degeneration, invade renal sinus perirenal fat, simulate angiomyolipoma – Large tumors may also have osseous metaplasia
  • 13.
    Renal Cell Carcinoma •Variable appearance and histology (continued) – Common RCC subtypes (WHO classification): Clear cell, papillary, chromophobe – Additional rare, aggressive renal epithelial tumors may be suggested by central infiltrative growth pattern (collecting duct, medullary carcinoma)
  • 14.
    Renal Cell Carcinoma •Large RCC with predilection for renal vein, inferior vena cava invasion
  • 19.
    Wilms Tumor (Nephroblastoma) •Most common solid renal mass in children • Highly variable appearance
  • 21.
    Column of Bertin(Mimic) • Hypertrophied column of septal cortex that protrudes into renal sinus – Usually between upper and middle calyces • Same enhancement characteristics (and echogenicity) as renal cortex • Utilize power (color) Doppler to confirm similar vascularity of adjacent cortex if identified at screening ultrasound
  • 23.
    Fetal Lobulation • Persistentcortical lobulation, reflecting fetal renal development as multiple separate lobes • Enhances like normal cortex and medulla
  • 24.
    Pyelonephritis • Severe focalpyelonephritis, renal abscess, or xanthogranulomatous pyelonephritis may be indistinguishable from tumor by imaging alone • Consider clinical presentation; needle aspiration and drainage of abscess
  • 26.
    Less Common Diagnosis •Hyperdense Renal Cyst (Mimic) • Angiomyolipoma, Renal • Renal Oncocytoma • Metastases and Lymphoma, Renal • Urothelial Cell Carcinoma • Pyelonephritis, Xanthogranulomatous • Renal Trauma • Aneurysm, Renal Artery (Mimic) • Arteriovenous Malformation, Renal (Mimic)
  • 27.
    Helpful Clues forLess Common Diagnoses
  • 28.
    Hyperdense Renal Cyst(Mimic) • High-density (“hyperdense” or “hemorrhagic”) renal cyst is indistinguishable from tumor on either NECT or CECT alone – Cyst will not enhance, while viable tumor almost always enhances ≥ 20 HU (beware papillary RCC) – Sonography useful to show sonolucent contents and acoustic enhancement of hyperdense cyst – Large cyst with extensive hemorrhage may be impossible to distinguish from necrotic tumor – Attenuation > 70 HU at NECT strongly suggests high- attenuation (“hyperdense”) CT rather than RCC
  • 29.
    Angiomyolipoma, Renal • Mostcommon benign renal solid mass • 95% have identifiable fat on CT or MR – Use NECT or MR to identify small foci of fat – AML without fat is difficult or impossible to distinguish from RCC by imaging (often hyperdense to kidney on NECT) – Highly echogenic at ultrasound, though imaging overlap with small echogenic RCC • Features favoring RCC: Halo, cystic components • Multiple and bilateral in tuberous sclerosis • May result in spontaneous bleeding
  • 31.
    Renal Oncocytoma • Benignepithelial tumor • Often has central stellate scar (30-50%), though not specific finding • Segmental inversion pattern suggested, though specificity also disputed – Hypervascular component on corticomedullary phase deenhances on nephrographic phase – Hypovascular component on corticomedullary phase retains contrast on nephrographic phase
  • 33.
    Metastases and Lymphoma,Renal • Often multiple, in patient with known primary tumor • Usually less vascular and less exophytic than RCC • Multiple renal lymphoma patterns: Multifocal or infiltrating tumor, diffuse bilateral enlargement • Consider lymphoma if large tumor and retroperitoneal adenopathy without renal vein invasion
  • 36.
    Urothelial Cell Carcinoma •More infiltrative, less expansile than RCC • May be part of multifocal tumor – Bladder > kidney > ureter • Most low-grade, superficial papillary masses • 15% aggressive: Invade renal sinus and parenchyma
  • 38.
    Renal Trauma • Renalhematoma may be indistinguishable from tumor – History (including possible invasive procedure like biopsy) is key • Traumatic injury will evolve quickly
  • 41.
    Aneurysms and Arteriovenous Malformations(Mimic) • Vascular lesions can mimic tumor • Key is multiphasic CT or MR during rapid bolus of contrast medium or color Doppler
  • 43.
    Rare but Important •Renal Medullary Carcinoma • Renal Tumors, Atypical and Rare – Mesenchymal Tumor, Renal – Juxtaglomerular Tumor – Plasmocytoma, Renal – Small Cell Carcinoma, Renal
  • 44.
    Helpful Clues forRare Diagnoses
  • 45.
    Renal Medullary Carcinoma •Rare, highly aggressive tumor • Usually affects men with sickle cell trait
  • 46.
    Renal Tumors, Atypicaland Rare • May arise from any mesenchymal component of renal capsule, cortex, or medulla • Generally cannot be diagnosed by imaging
  • 48.
    Alternative Differential Approaches • Lesionsthat may be hyperdense on NECT: Hyperdense cyst, RCC, oncocytoma, nonfat- containing AML, transitional cell carcinoma
  • 49.